Long-Term Results up to 12 Months After Catheter-Based Alcohol-Mediated Renal Denervation for Treatment of Resistant Hypertension
暂无分享,去创建一个
R. Schmieder | S. Bertog | D. Kandzari | H. Parise | A. Pathak | F. Mahfoud | H. Sievert | Michael A. Weber | M. van der Giet | T. Fischell | W. Wojakowski | A. Persu | S. Ewen | L. Lauder | Jean-Philippe Lengelé | M. Weber
[1] P. Blankestijn,et al. Catheter-based alcohol-mediated renal denervation for the treatment of uncontrolled hypertension: design of two sham-controlled, randomized, blinded trials in the absence (TARGET BP OFF-MED) and presence (TARGET BP I) of antihypertensive medications. , 2021, American heart journal.
[2] R. Whitbourn,et al. Renal Denervation in High-Risk Patients With Hypertension. , 2020, Journal of the American College of Cardiology.
[3] H. Parise,et al. Evaluation of Transcatheter Alcohol-Mediated Perivascular Renal Denervation to Treat Resistant Hypertension , 2020, Journal of clinical medicine.
[4] A. Kirtane,et al. Device-based therapies for arterial hypertension , 2020, Nature Reviews Cardiology.
[5] G. Chatellier,et al. Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies , 2020, European heart journal.
[6] M. Böhm,et al. Alcohol-Mediated Renal Denervation Using the Peregrine System Infusion Catheter for Treatment of Hypertension. , 2020, JACC. Cardiovascular interventions.
[7] G. Mancia,et al. Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry , 2019, European heart journal.
[8] M. Böhm,et al. Catheter-based renal denervation: the next chapter begins. , 2018, European heart journal.
[9] F. Ikeno,et al. Transcatheter Alcohol-Mediated Perivascular Renal Denervation With the Peregrine System: First-in-Human Experience. , 2016, JACC. Cardiovascular interventions.
[10] J. Staessen,et al. Renal Denervation for Treatment of Hypertension: a Second Start and New Challenges , 2016, Current Hypertension Reports.
[11] G. Chatellier,et al. Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design. , 2015, European heart journal.
[12] S. Anderson,et al. The aging kidney: physiological changes. , 2010, Advances in chronic kidney disease.
[13] V. Papademetriou,et al. Renal sympathetic denervation and systemic hypertension. , 2010, The American journal of cardiology.
[14] Daniel W. Jones,et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. , 2008, Circulation.